Clinical spectrum of anti-E: A thought for transfusion services
Authors:
Open Access
- 22 August 2024
- journal article
- Published by Medknow in Asian Journal of Transfusion Science
- Vol. 20 (2) , 481-484
Abstract
The rhesus system antigens are of immense clinical importance in transfusion medicine. They can stimulate the production of clinically significant antibodies. Anti-E is one of the most common alloantibodies reported in multi-transfused patients in India which is known to cause delayed hemolytic transfusion reaction and hemolytic disease of the fetus and newborn (HDFN). This antibody can have different clinical presentations and persist for a prolonged period in the plasma. In this case series, we report five such cases where anti-E antibodies were identified in different clinical settings. The clinical scenarios consist of HDFN, hematopoietic stem cell transplantation, and blood donors, where the anti-E antibody was detected during the immunohematological workup. The patients were managed according to the clinical spectrum of the antibody.Keywords
This publication has 9 references indexed in Scilit:
- The impact of pre-existing HLA and red blood cell antibodies on transfusion support and engraftment in sickle cell disease after nonmyeloablative hematopoietic stem cell transplantation from HLA-matched sibling donors: A prospective, single-center, observational studyeClinicalMedicine, 2020
- Routine indirect antiglobulin testing of blood donors—a further step toward blood safety: an experience from a tertiary care center in northern IndiaImmunohematology, 2020
- Transfusion-related red blood cell alloantibodies: induction and consequencesBlood, 2019
- Immune Reconstitution after Allogeneic Hematopoietic Stem Cell TransplantationFrontiers in Immunology, 2016
- Red cell alloimmunization in RhD positive pregnant women and neonatal outcomeTransfusion and Apheresis Science, 2016
- Importance of Clinically Significant Anti-M Antibody in Hematopoietic Stem Cell TransplantationIndian Journal of Hematology and Blood Transfusion, 2015
- Factors associated with persistence of red blood cell antibodies in woman after pregnancies complicated by fetal alloimmune haemolytic disease treated with intrauterine transfusionsBritish Journal of Haematology, 2014
- Passenger Lymphocyte Syndrome: A Case Report Involving Non-ABO AntibodiesTransfusion Medicine and Hemotherapy, 2014
- Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantationBlood, 2001